All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B, Chronic-32663786

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32663786	M204I	RT	P	Hepatitis B, Chronic	D G S C L	View
2	32663786	A317S	RT	P	Hepatitis B, Chronic	D G S C L	View
3	32663786	C256S	RT	P	Hepatitis B, Chronic	D G S C L	View
4	32663786	D263E	RT	P	Hepatitis B, Chronic	D G S C L	View
5	32663786	F122L	RT	P	Hepatitis B, Chronic	D G S C L	View
6	32663786	F122Y	RT	P	Hepatitis B, Chronic	D G S C L	View
7	32663786	H126Y	RT	P	Hepatitis B, Chronic	D G S C L	View
8	32663786	L180M	RT	P	Hepatitis B, Chronic	D G S C L	View
9	32663786	L91I	RT	P	Hepatitis B, Chronic	D G S C L	View
10	32663786	M204V	RT	P	Hepatitis B, Chronic	D G S C L	View
11	32663786	R153W	RT	P	Hepatitis B, Chronic	D G S C L	View
12	32663786	S223A	RT	P	Hepatitis B, Chronic	D G S C L	View
13	32663786	V173L	RT	P	Hepatitis B, Chronic	D G S C L	View
14	32663786	V278I	RT	P	Hepatitis B, Chronic	D G S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.